ANVSAnnovis Bio Inc
1.820USD+1.68%Mkt Cap: 77.54M $P/E: —3d ago
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's dise…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap77.54M $
Enterprise Value58.81M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-28.85M $
Revenue/Share—
Last Price1.820 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS03615A1088
Valuation
P/E (Trailing)—
P/E (Forward)-2.03
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-18.20
EPS (TTM)-1.75
EPS (Forward)-0.90
52W Range
1.5407% of range5.500
52W High5.500 USD
52W Low1.540 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-171.23%
ROA-136.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M $
CapEx (TTM)—
FCF Margin—
FCF Yield-30.69%
Net Debt-18.73M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.47
Quick Ratio2.94
Book Value/Sh-0.1000 USD
Cash/Share0.4400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.00 USD
Upside (mean)+504.4%
Target Range8.000 USD – 17.00 USD
$8.000+504.4% to mean$17.00
# Analysts3
Ownership
Shares Out.42.61M
Float35.31M
Insiders6.71%
Institutions27.91%
Short Interest
Short Ratio6.6d
Short % Float13.40%
Short % Out.12.21%
Shares Short5.19M
Short (prev mo.)4.86M
Technical
SMA 501.797 (+1.3%)
SMA 2002.488 (-26.9%)
Beta1.24
S&P 52W Chg19.18%
Avg Vol (30d)699.86K
Avg Vol (10d)586.25K
Technical Indicators
RSI (14)51.2
MACD-0.0014
MACD Signal-0.0042
MACD Hist.+0.0027
BB Upper1.918 USD
BB Middle1.783 USD
BB Lower1.647 USD
BB Width15.20%
ATR (14)0.1105 USD
Vol Ratio (20d)1.04x